Dominari Holdings Inc. (NASDAQ:DOMH) Short Interest Up 1,826.2% in January

Dominari Holdings Inc. (NASDAQ:DOMH) saw a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 287,000 shares, an increase of 1,826.2% from the January 15th total of 14,900 shares. Based on an average trading volume of 1,040,000 shares, the days-to-cover ratio is presently 0.3 days. Approximately 8.3% of the company’s shares are sold short.

Dominari Stock Down 7.9 %

DOMH opened at $6.87 on Thursday. The business has a fifty day moving average of $1.95 and a 200 day moving average of $1.81. Dominari has a 52-week low of $0.83 and a 52-week high of $11.33. The stock has a market cap of $43.56 million, a P/E ratio of -1.78 and a beta of 1.25.

Dominari Company Profile

Dominari Holdings Inc, a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.